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Abstract
Background: Staphylococcus aureus releases virulence factors (VF) that may impair the innate protective functions
of airway cells. The aim of this study was to determine whether a long-acting b2 adrenergic receptor agonist
(salmeterol hydroxynaphthoate, Sal) combined with a corticosteroid (fluticasone propionate, FP) was able to
regulate ion content and cytokine expression by airway glandular cells after exposure to S. aureus supernatant.
Methods: A human airway glandular cell line was incubated with S. aureus supernatant for 1 h and then treated
with the combination Sal/FP for 4 h. The expression of actin and CFTR proteins was analyzed by
immunofluorescence. Videomicroscopy was used to evaluate chloride secretion and X-ray microanalysis to measure
the intracellular ion and water content. The pro-inflammatory cytokine expression was assessed by RT-PCR and
ELISA.
Results: When the cells were incubated with S. aureus supernatant and then with Sal/FP, the cellular localisation of
CFTR was apical compared to the cytoplasmic localisation in cells incubated with S. aureus supernatant alone. The
incubation of airway epithelial cells with S. aureus supernatant reduced by 66% the chloride efflux that was fully
restored by Sal/FP treatment. We also observed that Sal/FP treatment induced the restoration of ion (Cl and S) and
water content within the intracellular secretory granules of airway glandular cells and reduced the bacterial
supernatant-dependent increase of pro-inflammatory cytokines IL8 and TNFa.
Conclusions: Our results demonstrate that treatment with the combination of a corticosteroid and a long-acting
b2 adrenergic receptor agonist after bacterial infection restores the airway glandular cell function. Abnormal mucus
induced by defective ion transport during pulmonary infection could benefit from treatment with a combination
of b2 adrenergic receptor agonist and glucocorticoid.
Background
The epithelial lining of the airways provides an efficient
barrier against microorganisms through interdependent
functions including mucociliary clearance, homeostasis
of ion and water transport, biochemical responses and
acts as a cellular barrier function by means of intercellu-
lar junctions. These functions are fundamental to the
maintenance of the defence and the integrity of the air-
way epithelium which may be disturbed after any infec-
tious insult in diseases such as chronic obstructive
pulmonary disease (COPD) or cystic fibrosis (CF).
Staphylococcus aureus (S. aureus) is one of the most
common gram-positive bacteria involved in airway infec-
tions, either primary or subsequent to viral diseases [1].
S. aureus is also a major cause of hospital acquired
lower respiratory tract infections and is often implicated
in early infectious airway disease in CF patients [2]. S.
aureus expresses several potential virulence factors (VF)
that may induce airway epithelium injury and impair the
epithelial wound/repair process [3]. Remodeling that
occurs following injury may considerably disturb the
innate protective function of the respiratory epithelium.
Abnormal expression and distribution of CFTR protein
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way tissues [4] and may thereby induce alteration of the
airway mucus mainly produced by the airway glandular
cells [5,6]. Abnormal mucus production is the hallmark
of chronic inflammatory airway diseases such as asthma,
chronic bronchitis, and CF [7,8]. Sputum has altered
macromolecular composition and biophysical properties
which vary with disease, but unifying features are failure
of mucociliary transport resulting in airway obstruction
[9]. Protection of the airway epithelium or restoration of
its function requires factors that prevent or reverse cel-
lular damage caused by bacterial VF. There is already
evidence of enhanced respiratory cytoprotection against
bacterial infection when airway epithelial cells are pre-
incubated with a long-acting beta-2 adrenergic receptor
(b2AR) agonist [10]. Furthermore, the increased CFTR
expression associated with b2AR stimulation may have
other beneficial effects on ion and water transport, pro-
tein expression and differentiation [11]. We have also
shown that pre-treatment with the combination of a
long-acting b2AR (salmeterol hydroxynaphthoate, Sal)
and a corticosteroid (fluticasone propionate, FP) induces
a downregulation of S. aureus-induced airway epithelial
inflammation, particularly by modulating the expression
of cytokines such as IL-6, IL-8 or TNFa [12].
Although previous studies have shown a preventive
role of combined b2AR agonist/corticosteroid (Sal/FP)
on COPD exacerbations [13] and bacterial VF-induced
alterations in human airway epithelial cells, the role of
this combination used as a treatment to correct the
deleterious effect of bacterial VF is currently unknown.
In addition, whether bacterial infection of airway epithe-
lial cells may induce alterations in ion transport and loss
of epithelial electrolyte homeostasis has not been exten-
sively investigated. Therefore, the aim of this study was
to determine whether Sal/FP combination is able to
restore intracellular ion and water content and inflam-
matory cytokine expression previously altered by Sa u r -
eus supernatant. The experiments were performed on an
airway glandular cell line since these cells are the main
source of airway mucus and associated secretion pro-
ducts (ions, mucins, cytokines,) [6]. In addition these
cells are characterized by numerous intracellular secre-
tory granules which can be analyzed in terms of ion
concentration. Since S. aureus VF have been demon-
strated to be able to disrupt actin cables [14] and that
this disruption may lead to CFTR delocalisation [15], we
also investigated the effect of Sal/FP treatment on actin
and CFTR cellular localisation. The use of Sal/FP com-
bination is based upon experiments by which tissues
incubated with low concentrations of Sal/FP would sup-
port a synergistic action between the two compounds
and that the higher concentrations showed no added
benefit with respect to mucosal damage compared to
either agent alone at the same concentration [16].
Our results demonstrate that S. aureus VF produced
during airway infection induce alterations of ion and
water content in airway secretory granules, which may
be at the onset of decreased mucociliary clearance fre-
quently observed during pulmonary infection exacerba-
tions [17]. Treatment with a corticosteroid combined
with a b2AR agonist is able to correct these anomalies
and may be helpful for restoring normal cytoprotective
properties of the airway epithelium.
Methods
Preparation of bacterial supernatant
S. aureus strain 8325-4, a wild-type laboratory strain
(fibronectin-binding protein (FnBP) A
+ and FnBPB
+,
NTC 8325 cured of prophages), was a generous gift
from T.J. Foster (Department of Microbiology, Trinity
College, Dublin, Ireland). Bacterial supernatant was pre-
pared by growing bacteria in trypticase soy broth (TSB,
AES Laboratoire, Bruz, France) for 16-18 h at 37°C
under agitation (120 rpm). Supernatant of 5 × 10
8 cfu/
ml was obtained by centrifugation at 960 g for 10 min
at 4°C, then filtration through a 0.2 μm filter (Pall Gel-
man Science, Ann Arbor, Michigan). The supernatant
containing S. aureus soluble VF was diluted to 2%, 10%
or 20% in Dulbecco’s modified Eagle’sm e d i u m
( D M E M ) / F - 1 2( S i g m aA l d r i c h ,S tL o u i s ,M O ) .T S Bw a s
used as control at 2, 10 or 20% in DMEM/F-12.
Preparation of salmeterol hydroxynaphthoate and
fluticasone propionate
Salmeterol hydroxynaphthoate (Sal), provided by Glax-
oSmithKline (Uxbridge, UK), was dissolved in a mini-
mum amount of glacial acetic acid (30 μl), then diluted
to a concentration of 2 × 10
-4 M in phosphate-buffered
saline (PBS; Gibco, Invitrogen, Paisley, UK) and kept at
-20°C. The solution was buffered to a pH of 7.4. The
stock solution was used at a final concentration of 2 ×
10
-7 M in DMEM/F-12 previously defined as optimal for
inducing airway epithelial cytoprotection [18].
A stock solution of fluticasone propionate (FP) pro-
vided by GlaxoSmithKline was prepared (1 × 10
-5 M) in
1 mM ethanol (Merck Eurolab, Darmstadt, Germany).
FP was diluted with DMEM/F-12 medium to a final
concentration of 1 × 10
-8 M, a concentration previously
found to have anti-inflammatory effects in bronchial
epithelial cells [19].
Cell culture and experimental procedure
The transformed human tracheal glandular cell line
MM-39 [20] was grown in DMEM/F-12 supplemented
with 1% Ultroser G serum substitute (Biosepra, Ville-
neuve-la-Garenne, France), glucose (10 g/l), sodium pyr-
uvate (0.33 g/l), penicillin (100 IU/ml), streptomycin
(100 μg/ml) and amphotericin B (2 μg/ml) on porous
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coated with type I collagen (50 μg/ml) prepared as pre-
viously described [21] and was cultured at 37°C under a
5% CO2 atmosphere. In a first set of experiments to
determine the effect of S. aureus supernatant on cell
death, cells were incubated with 2%, 10% or 20% of S.
aureus supernatant or with medium alone (DMEM/F-12
supplemented with 2%, 10% or 20% of TSB) for 5 hours.
In the subsequent experiments, cells were incubated
with either control medium alone (DMEM/F-12 supple-
mented with 2% of TSB), or in presence of S. aureus
supernatant (2%) for 1 h, then treated with Sal/FP (2 ×
10
-7 Ma n d1×1 0
-8 M, respectively) or vehicles (glacial
acetic acid and ethanol) for 4 h.
Assessment of cell viability
A fluorescence staining method using propidium iodide
and syto9 (Molecular Probes, Eugene, OR) was used to
study the cell death/viability of airway epithelial cells
incubated with S. aureus supernatant. Propidium iodide
only penetrates into cells with damaged membranes,
staining the cells in red, whereas syto9 penetrates into
all cells, staining them in green. Briefly, at cell culture
confluence, medium was removed from the culture
plates, and cells were washed three times with sterile
PBS and incubated with 2%, 10% or 20% of S. aureus
supernatant or TSB, propidium iodide (1 μl/ml) and
syto9 (1 μl/ml). Culture dishes were placed on the stage
of an inverted microscope (Axiovert 200 M; Zeiss, Le
Pecq, France) equipped with an environmental chamber
(37°C, 5% CO2, 100% relative humidity) and with a
charge-coupled device video camera (Coolsnap Fx;
Roper Scientific, Tucson, AZ). Using Metamorph (Uni-
versal Imaging, Downingtown, PA) software, we
recorded time-lapse fluorescent images every hour for 5
h. Variations of the fluorescence intensity of propidium
iodide were related to the variation of the number of
dead cells. To assess the cell viability, airway glandular
cells were seeded on a 96 well microplate. At conflu-
ence, they were incubated for 5 h with 2%, 10% or 20%
of S. aureus supernatant or TSB in culture medium and
then for 1 hour with 1 mg/ml methylthiazolyldiphenyl-
tetrazolium bromide (MTT, Sigma Aldrich, St Louis,
MO). The dye was extracted with propanol-2 and the
OD at 560 nm was read in a Xenius spectrophotometer
(Safas, Monaco).
Western blot analysis
For membrane extract, 2% S. aureus supernatant-treated
or 2% TSB-treated cells were disrupted mechanically in
cold Tris buffer (50 mM Tris-HCL pH 7.5, 1 mM
EDTA with complete protease inhibitor mixture (Roche
Applied Science) for 15 min on ice and precipitated at
4°C overnight with 4% (v/v) trichloroacetic acid. After
centrifugation (2500 g for 10 min at 4°C), the pellet was
dissolved in 100 μl RIPA buffer. Six μgo fp r o t e i n
extracts were separated by electrophoresis on 7.5% SDS-
polyacrylamide gels and electroblotted to PVDF mem-
branes using 100 V for 1 h at 4°C. Membranes were
incubated for 1 h in a blocking buffer containing 5%
non-fat dry milk in PBS with 0.1% Tween 20, then over-
night with mouse anti-CFTR antibody (clone 24-1,
1:1000, R&D Systems, Lille, France) or with rabbit anti-
actin antibody (A2066, 1:1000, Sigma-Aldrich, St Louis
MO, USA) and finally with horseradish peroxidase
(HRP)-conjugated anti-mouse immunoglobulin antibody
(1:1,000; DakoCytomation, Glostrup, Denmark) or
horseradish peroxidase (HRP)-conjugated anti-rabbit
immunoglobulin antibody (1:1000, DakoCytomation).
Blots were revealed by using an ECL+ kit (GE Health-
care, Little Chalfont, UK) and analyzed by densitometry
with a Fuji Las-1000 (Raytest, Courbevoie, France).
Actin and CFTR co-localisation by immunocytochemistry
To detect actin by immunofluorescence, we used an affi-
nity isolated antigen specific antibody obtained from
rabbit anti-actin antiserum by immuno-specific purifica-
tion (A2066, 1:25, Sigma-Aldrich, St Louis MO, USA)
[22]. CFTR was detected using the MAB25031 antibody
(clone 24-1, diluted 1:100, R&D Systems, Lille, France)
which is recommended by the European Working
Group on CFTR expression [23]. MM-39 cells were
seeded onto glass slides coated with type I collagen (50
μg / m l )a n df i x e da tc o n f l u e n c ew i t hc o l dm e t h a n o lf o r
10 min at -20°C. After sequential incubation with the
anti-actin antibody, Alexa Fluor 594-conjugated goat
anti-rabbit antibody (1:200, Molecular Probes, Eugene,
OR), anti-CFTR antibody and Alexa Fluor 488-conju-
gated goat anti-mouse antibody (1:200, Molecular
Probes), cells were incubated for 10 min with DAPI
(4’,6’-diamino-2-phenylindole, 200 ng/ml, Sigma
Aldrich) for nuclear staining, then mounted with Aqua-
polymount antifading solution (Polysciences, Warring-
ton, Pennsylvania) onto glass slides. Slides were
observed under an AxioImager fluorescence microscope
(Zeiss, Le Pecq, France) equipped with an apotome
device (Zeiss). Images were recorded with a CCD video
camera (Coolsnap, Roper Scientific, Tucson, AZ) at 40
successive z levels (0.25 μm between each z level) at
×63 magnification. The Metamorph software (Universal
Imaging, Sunnyvale, CA) was used to quantify regions of
overlap of actin and CFTR fluorescence. Both source
images were thresholded and the areas of overlap were
determined by calculating the number of pixels of actin
staining overlaping with CFTR staining. Data were
expressed in percentage of pixel overlap.
Measurement of chloride efflux
The chloride efflux in airway epithelial cells was evalu-
ated by videomicroscopy using the halide-quenched dye
6-methoxy-N-(3-sulfopropyl) quinolinium probe (SPQ,
Molecular Probes) in a chloride buffer solution (130
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CaSO4,1m MM g S O 4, and 10 mM Hepes) made hypo-
tonic by adding an equivalent volume of water, as pre-
viously described [24]. Thereafter, the hypotonic
chloride buffer was replaced by an isotonic chloride buf-
fer for 15 minutes and then by a nitrate buffer in which
the NaCl was replaced by 130 mM of NaNO3.T h ec u l -
ture dish was placed on the heated stage of an inverted
m i c r o s c o p e( T E3 0 0 ;N i k o n ,C h a m p i g n ys u rM a r n e ,
France). After 30 seconds, amiloride (10 μM), and 1.5
minutes later, forskolin (25 μM), were added to the
nitrate buffer. Throughout the experimental process,
fluorescence images lex at 365 nm and lem at 395 nm)
were recorded every 15 seconds using a Micromax CCD
camera and the Metafluor software (Roper Scientific,
Evry, France). Chloride efflux was calculated by measur-
ing the variations in SPQ fluorescence (ΔF/Δt) over a
1.5 min incubation period after the addition of forskolin,
and expressed as arbitrary units. In some experiments,
the cells were incubated for 1 h in serum-free culture
medium containing 5 μMC F T R inh-172 (Sigma Aldrich),
which is a thiazolidinone CFTR inhibitor [25].
Ion and water content analysis
Ion and water content was determined using electron
probe X-ray microanalysis and a quantitative dark field
intensity technique with a scanning transmission elec-
tron microscope (STEM CM30, Philips) for measuring
the in situ ion and water content in the cytoplasm and
in the secretory granules of entire cryofixed cells [26].
In practice, the cryosection of cells irradiated by an elec-
tron beam emits an X-ray signal. The emission spec-
trum corresponds to the counting of X-rays emitted
according to their energy. The intensity ratio specific
peak/background allows the measurement of the con-
centrations of all the elements detected in the spectrum.
To obtain the exact value of the mass concentrations
(mmol/kg dry weight) of the elements of interest (Na,
M g ,S ,C la n dK ) ,w em e a s u r e du n d e rt h es a m ee x p e r i -
mental conditions, the specific peak/background ratio of
the elements compared with standard samples of known
mass concentrations. The mass concentrations in mmol/
kg of dry matter (Cd) can be converted into mmol/l of
water (Ch)b yu s i n gt h ee q u a t i o nC h = ((100 - L)/L) ×
Cd where L is the percentage of water determined by
quantitative dark field imaging. The water mass content
was deduced from the complement to 100% of dry mass
content measured on the dark field images. We devel-
oped an original method for intracellular water content
quantification with high spatial resolution (< 30 nm)
based on dark field imaging. A hydrated cryosection
contains a dry mass percentage (M) and its water com-
plement (L) with L + M = 100%. During biological sam-
ple freeze-drying inside the microscope column, water
(under amorphous ice sate) is sublimed and then the
relative dark field intensity becomes directly propor-
tional to the percentage of sample dry mass. By image
processing, we obtained a parametric image in which
the grey levels were proportional to the mass water con-
tent (L). The intracellular water content (L) was calcu-
lated by comparison with relative dark field intensities
of standard samples with known water content. Accord-
ing to the different experimental conditions, 36 to 65
secretory granules from 14 to 21 cells were analyzed.
Prior to the quantitative X-ray microanalysis, we showed
that the K/Na ratio in the nucleus and in the cytoplasm
was higher than 5, which is a characteristic of living
confluent cells [27].
Cytokine secretion measurement
Culture medium was collected and cytokine protein
levels were determined using sandwich enzyme-linked
immunoabsorbent assays (ELISA) for IL-8, IL-6 and
high-sensitivity TNFa detection (R&D Systems, Minnea-
polis, MN) following the manufacturer’si n s t r u c t i o n s .
Results are expressed as pg/ml.
RNA extraction and Reverse Transcriptase-Polymerase
Chain Reaction analysis
RNA extraction of cells was performed with the High
Pure RNA isolation kit (Roche Diagnostics GmBH,
Mannheim, Germany) following the manufacturer’s
instructions. Reverse transcriptase (RT)-polymerase
chain reaction (PCR) was performed with 10 ng of total
RNA using the GeneAmp Thermostable RNA PCR Kit
(Perkin Elmer, Foster City, CA) and three pairs of oligo-
nucleotides (Eurogentec, Seraing, Belgium). Forward and
reverse primers for human IL-8, TNF-a, and 28 S were
designed as follows: IL-8 primers, forward 5’-GCCAAG-
GAGTGCTAAAGAACTTAG-3’, reverse 5’-GAATTCT-
CAGCCCTCTTCAAAAAC-3’;T N F - a primers, forward
5’-CAGCCTCTTCTCCTTCCTGA-3’,r e v e r s e5 ’-
TGAGGTACAGGCCCTCTGAT-3’ and 28 S primers,
forward 5’-GTTCACCCACTAATAGGGAACGTGA-3’,
reverse 5’-GGATTCTGACTTAGAGGCGTTCAGT-3’.
For the IL-8 PCR, an initial denaturation at 95°C for 2
min was followed by 25 amplification cycles (denatura-
tion at 94°C for 15 sec, annealing at 60°C for 20 sec,
and elongation at 72°C for 10 sec) and a final 2-min
elongation at 72°C. For the TNF-a PCR, the conditions
were as follows: initial denaturation (94°C, 2 min), 29
amplification cycles (denaturation 94°C, 30 sec, anneal-
ing 59°C, 30 sec, and elongation 72°C, 30 sec) and final
elongation (72°C, 7 min). For the 28 S PCR, the condi-
tions were as follows: initial denaturation (95°C, 2 min),
13 amplification cycles (denaturation 94°C, 15 sec,
annealing 66°C, 20 sec, and elongation 72°C, 10 sec),
final elongation (72°C, 2 min). The expected sizes of the
transcripts of IL-8, TNF-a and 28 S were 222 bp, 302
bp and 212 bp, respectively. RT-PCR products were
separated by acrylamide gel electrophoresis, stained with
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metric scanning (Fuji, LAS-1000, Raytest, France). The
IL-8 and TNF-a mRNA values were normalized to 28 S
mRNA values. Results represent the mean ± SD of eight
independent experiments performed in duplicate.
Data analysis
Values were reported as mean ± SEM. Non parametric
Man and Whitney test and one-way Kruskall-Wallis test
were used for comparisons between groups and differ-
ences were considered to be statistically significant with
P values less than 0.05.
Results
Effect of S. aureus supernatant on cell viability
To assess the effect of S. aureus supernatant on cell via-
bility, airway glandular cells were incubated with
increasing concentrations of bacterial supernatant. Cell
death was evaluated by using the propidium iodide
fluorescent probe and cell viability by using the MTT
assay. Figure 1A displays fluorescent images recorded
after 5 hours of incubation with S. aureus supernatant.
In control condition or in presence of 2% S. aureus
supernatant, a limited number of cells showed a red
nucleus staining characteristic of dead cells, whereas the
number of dead cells dramatically increased in presence
of 10% or 20% of S. aureus supernatant. A typical time-
dependent increase in red fluorescent staining is dis-
played in figure 1B, showing a similar curve pattern for
the control experiment and the experiment in presence
of 2% S. aureus supernatant. The comparison of the
grey levels of the red fluorescence after 5 h of incuba-
tion with S. aureus supernatants is shown in figure 1C.
A significant increase in fluorescence, reflecting the
increase in cell death, was observed when the cells were
incubated with 10% or 20% of S. aureus supernatant (p
< 0.01). In parallel, using the MTT technique, we quan-
tified by OD measurement the number of living cells
and observed that this number significantly (p < 0.01)
decreased in presence of 10 or 20% of S. aureus super-
natants (figure 1C). From these data we can therefore
conclude that the incubation for 5 h with 2% S. aureus
supernatant did not significantly altered the cellular
viability.
Effect of S. aureus supernatant on CFTR expression
Immunofluorescence and Western blotting were used to
test the effect of S. aureus supernatant on CFTR expres-
sion at the cell membrane level. As shown in figure 2,
we observed that the incubation of airway glandular
cells with 2% S. aureus supernatant reduced the expres-
sion level of CFTR at the cell membrane, indicating a
delocalisation of this protein from the apical membrane.
CFTR localisation was assessed by using immunofluor-
escence imaging at different z levels. Figure 2A and 2B
shows the cellular distribu t i o no fC F T Ri nal a t e r a l
image obtained from different z levels. In the control
cells (figure 2A) we observed a high staining at the api-
cal pole of cells. In the cells treated with 2% S. aureus
supernatant, we observed the loss of the CFTR staining
at the apical pole and a more diffuse cytoplasmic stain-
ing. We performed complementary western blotting
analysis on cell membrane extracts (figure 2C) and mea-
sured a significant (p < 0.05) decrease in CFTR expres-
sion when the cells were incubated with 2% S. aureus
supernatant (figure 2D).
Actin and CFTR co-localisation is restored by Sal/FP
treatment
Since it has been previously demonstrated that CFTR
may directly bind actin and that this interaction may
affect the functional properties of this channel protein
[28], we aimed at analyzing the effect of S. aureus super-
natant on actin and CFTR relationship. For that pur-
pose, we examined the co-localisation of these proteins
by immunofluorescence. The pattern of staining of
CFTR (green staining) and actin (red staining) was
essentially apical in control cells (figure 3A). The incu-
bation of cells with Sal/FP enhanced the apical localisa-
tion of CFTR (figure 3B). In contrast, incubation of cells
with 2% S. aureus supernatant induced an alteration in
the localisation of CFTR which appeared to be more
cytoplasmic (figure 3C) as previously shown in figure 2.
Treatment of cells with Sal/FP restored CFTR and actin
apical localisation (figure 3D). Quantification of the co-
localisation of CFTR and actin (figure 3E) showed that
2% S. aureus supernatant decreased by 47% the co-loca-
lisation index compared with control cells, but the dif-
ference was not statistically significant. Interestingly,
treatment with Sal/FP alone or after S. aureus superna-
tant incubation significantly enhanced the co-localisa-
tion of the 2 proteins compared with control cells (p <
0.05) or with S. aureus supernatant-treated cells (p <
0.05).
S. aureus supernatant altered chloride efflux, ion and
water content
We next analyzed the time-dependent effect of 2% S.
aureus supernatant incubation on cAMP-mediated
chloride efflux, and on cytoplasm and secretory granule
ion and water content in airway epithelial cells. As
shown in figure 4A, a significant (p < 0.01) time-depen-
dent decrease in chloride efflux was observed after 4
hours of incubation with 2% S. aureus supernatant. This
decrease became significant after 1 hour (36%) and
reached 70% after 4 h incubation. To test whether the
effect of S. aureus supernatant on chloride secretion was
specific to CFTR function alteration, we compared the
effect of S. aureus supernatant with the effect of a CFTR
inhibitor. We observed that incubation of airway gland-
ular cells with the CFTR inhibitor significantly reduced
(p < 0.01) the chloride secretion and that this decrease
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tion with 2% S. aureus supernatant (figure 4B).
Figure 5 shows the time-dependent effect of S. aureus
supernatant on the ion concentration and water content
measured either in the cell cytoplasm or in the secretory
granules. After 2 hours of incubation with S. aureus
supernatant, we observed a significant (p < 0.05)
increase in sodium concentration and a decrease in sul-
fur and chloride concentrations in the cytoplasm (figure
5A). In the secretory granules, 1 hour of incubation
with S. aureus supernatant induced a significant increase
(p < 0.05) in sulphur and potassium concentrations and
in parallel a significant (p < 0.05) decrease in chloride
concentration (figure 5B). The water content was signifi-
cantly decreased in the cytoplasm (figure 5C, p < 0.05)
and in the secretory granules (figure 5D, p < 0.01) after
2 and 4 hours of incubation with S. aureus supernatant,
respectively.
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Figure 1 Effect of S. aureus supernatant on cell death. Cell death induced by S. aureus supernatant. (A) Propidium iodide fluorescent probe
(red staining) was used to visualize the dead cells and syto 9 fluorescent probe (green staining) was used to visualize all the cells. The number
of dead cells was increased in presence of 10% or 20% of S. aureus supernatant. (B) Time-dependent increase in fluorescence intensity of
propidium iodide in presence of the different concentrations of S. aureus supernatant. (C) Fluorescence intensity of the propidium iodide probe
after 5 h of incubation with the different concentrations of S. aureus supernatant. The increase in fluorescence was significant when the cells
were incubated with 10% or 20% of S. aureus supernatant (*, p < 0.05; data represent the mean ± SEM of 3 different experiments). In parallel,
the MTT technique showed the number of living cells. The decrease of OD was significant when the cells were incubated with 10% or 20% of S.
aureus supernatant (**, p < 0.01; data represent the mean ± SEM of 8 different wells).
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We analyzed the effect of Sal/FP combination on the
chloride efflux and ion and water content in airway
epithelial cells. The cells were incubated for 1 h with 2%
S. aureus supernatant and then with Sal/FP for 4 h. As
shown in figure 6, we observed a significant decrease (p
< 0.01) in chloride efflux after 1 h incubation with 2% S.
aureus supernatant compared to control cells. Incuba-
tion of airway epithelial cells with Sal/FP restored the
chloride efflux previously decreased by S. aureus super-
natant. Interestingly, incubation of cells with Sal/FP
alone significantly (p < 0.05) enhanced the chloride
efflux. We observed that Sal/FP treatment did not sig-
nificantly modify the cytoplasmic ion and water content
(data not shown), but significantly increased the chloride
content (26 ± 4 mM versus 16 ± 5 mM p < 0.05) and
decreased the sulfur (31 ± 2 mM versus 42 ± 6 mM, p <
0.01) and potassium (72 ± 3 mM versus 86 ± 8 mM, p <
0.05) content in the secretory granules, compared with
the S. aureus supernatant-treated cells (figure 7).
Sal/FP treatment downregulates S. aureus supernatant-
induced airway epithelial cytokine release
We investigated whether following the incubation of air-
way epithelial cells with S. aureus supernatant, treat-
ment with Sal/FP was able to modulate cytokine release.
Incubation of epithelial cells with S. aureus supernatant
for 1 h induced a 12-fold, 21-fold and 21-fold increase
(p < 0.01) in the release of IL-8, TNFa and IL-6, respec-
tively, compared with control cells (figure 8A, B and
8C). Interestingly, following 1 h incubation of epithelial
cells with S. aureus supernatant, a 4 h Sal/FP treatment
significantly (p < 0.01) reduced the S. aureus superna-
tant-induced IL-8 release (28%, figure 8A). Sal/FP treat-
ment also decreased (p < 0.05) S. aureus supernatant-
induced TNFa secretion (50%, figure 8B) whereas it had
no effect on S. aureus supernatant-induced IL-6 release
(figure 8C).
Figure 2 Effect of S. aureus supernatant on CFTR localisation and expression. (A, B) Immunolocalisation of CFTR (green staining) and Dapi
nuclei staining (blue) in lateral view of successive z level images. In control cells, we noticed an apical staining of CFTR (arrow heads in A). In 2%
S. aureus supernatant-treated cells (B), the CFTR staining was more diffuse in the cytoplasm. (C) Western blotting analysis of airway glandular cell
membrane proteins showed the presence of CFTR in control cells and in fewer amount in cells incubated with 2%S. aureus supernatant. (D)
Quantitative measurement showed a significant (*, p < 0.05) decrease in CFTR expression in cell membranes when cells were incubated with 2%
S. aureus supernatant. Data represent the mean ± SEM of 5 different experiments.
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Page 7 of 15Figure 3 Co-localisation by immunofluorescence of CFTR and actin. (A) The pattern of CFTR (green staining) and actin (red staining)
stainings was essentially apical in control cells as well as in cells treated with Sal/FP (B). (C) The incubation of cells with S. aureus supernatant
induced alteration of the localisation of CFTR that appeared to be cytoplasmic, in parallel with a disorganization of the actin network. (D)
Treatment of S. aureus supernatant pre-incubated cells with Sal/FP restored CFTR and actin apical stainings. (E) Quantification of the co-
localisation of CFTR and actin showed that 2% S. aureus supernatant decreased the co-localisation index compared to the index in control cells,
but the difference was not significant; the treatment with Sal/FP alone or after S. aureus supernatant incubation significantly enhanced the co-
localisation of the 2 proteins compared with control or with S. aureus supernatant-treated cells (*, p < 0.05). Data represent the mean ± SEM of
3 different experiments.
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Page 8 of 15Sal/FP treatment downregulates S. aureus supernatant-
induced airway epithelial cytokine mRNA levels
We next determined by semi-quantitative RT-PCR the
effects of Sal/FP on S. aureus supernatant-induced IL-8
and TNFa mRNA levels. As shown in figure 9, incuba-
tion of epithelial cells with S. aureus supernatant for 1 h
induced a 5-fold and a 3.5-fold increase (p < 0.05) in IL-
8 (figure 9A) and TNFa mRNA (figure 9B) levels,
respectively, compared with control cells. Following 1 h
incubation of epithelial cells with S. aureus supernatant,
Sal/FP treatment for 4 h significantly (p < 0.05) reduced
S. aureus supernatant-induced IL-8 mRNA level (36%,
Figure 9A), but had no significant effect on TNFa(figure
9B).
Discussion
In the present study, we show that the treatment of air-
way epithelial cells with a combination of a corticoster-
oid and a long-acting b2AR agonist, after incubation
with S. aureus supernatant, restores the function of air-
way glandular epithelial cells previously altered by bac-
terial VF. We pre-incubated airway glandular cells with
crude extracts from S. aureus, which contain many
types of VF including toxins and proteases. The main
purpose of the present work was to evaluate the effect
of drugs able to restore the airway epithelium functions
rather than to pinpoint which bacterial factors are
responsible for the alterations of these functions. We
have chosen to test the effect of the combination of Sal
and FP since it has been previously demonstrated that
this combination induced a marked increase in the
nuclear glucocorticoid receptor expression in airway
epithelial cells and a significant synergistic decrease of
IL-8, IL-6 and TNF-a, at both transcriptional and trans-
lational levels [12].
It has been suggested by Nadel and Borson [29] that
ion transport in airways can be severely altered during
infection and inflammation. Indeed, Swiatecka-Urban et
al [30] reported that a cell-free filtrate of Pseudomonas
aeruginosa reduced CFTR-mediated transepithelial
chloride secretion by inhibiting the endocytic recycling
of CFTR. Our results are in accordance with recent stu-
dies which reported that recombinant sphingomyelinase
C (membrane-damaging virulence factor originally called
b-hemolysin) from S. aureus strongly inhibited CFTR-
dependent chloride current and that the cytoskeleton
was remodelled through the acid sphingomyelinase/cera-
mide pathway [31,32]. Moreover, it has been previously
demonstrated that actin cytoskeleton organization was
required for cAMP-dependent activation of CFTR
[33,34]. It is likely that the decreased activity of CFTR
observed in presence of S. aureus supernatant could be
related to the disruption of the actin cytoskeleton, lead-
ing to delocalisation and consequently inhibition of
CFTR as demonstrated here by immunofluorescence.
Glucocorticoids have been shown to increase the stabi-
lity of actin filaments, increase actin polymerization,
activate cytoskeleton-associated kinases and stabilize
actin filaments against disruption by injury [35]. We
hypothesize that incubation of S. aureus supernatant-
treated cells with FP might prevent actin cytoskeleton
degradation, leading to the recovery of functional CFTR
chloride channels. In addition to the effect of FP on
CFTR function, Taouil et al [11] previously demon-
s t r a t e dt h a tt h eb2-AR agonist Sal was able to increase
CFTR expression in human airway epithelial cells. It is
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Page 9 of 15also known that actin can interact directly or indirectly
with epithelial ion channels through scaffolding proteins
(NHERFs) or actin-binding proteins. Ganeshan et al
[36] demonstrated that CFTR surface expression and
chloride current were decreased by inhibitors of actin
polymerisation. Together, these data indicate that modu-
lation of the actin cytoskeleton may be a mechanism for
regulating the CFTR function. Our findings also support
the hypothesis that infection alters airway epithelial ion
transport and that combination treatment with
glucocorticoids and long-acting b2-AR agonists may be
helpful in restoring normal epithelial ion transport
function.
At the cytoplasmic level, we observed that S. aureus
supernatant induced an increase in sodium concentra-
tion, which reflected an inability to regulate sodium
absorption, likely related to a reduced CFTR function at
the apical membrane. The reduced CFTR function is
likely linked to CFTR delocalisation as assessed by
immunocytochemistry. As a biological significance, one
can compare this 3-fold increase in sodium
Figure 5 Time-dependent effect of S. aureus supernatant on the ion and water content. (A) We observed a significant (*, p < 0.05) time-
dependent increase in sodium concentration and decrease in sulfur and chloride concentrations in the cell cytoplasm. (B) In the secretory
granules, S. aureus supernatant incubation induced a significant increase in sulfur and potassium concentrations (*, p < 0.05; **, p < 0.01) and in
parallel a significant (*, p < 0.05) decrease in chloride concentration. (C) The water content was significantly decreased in a time-dependent way
by S. aureus supernatant in the cytoplasm and (D) in the secretory granules (*, p < 0.05). Data represent the mean ± SEM from 36 to 65
cytoplasmic areas or secretory granules from 14 to 21 cells.
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Page 11 of 15concentration to the 5-fold increase that we observed
when comparing sodium content in secretory granules
from non-CF and CF cells [37]. This increase was
accompanied by a decrease in cytoplasmic chloride con-
centration, despite the defect of cAMP CFTR-mediated
chloride secretion assessed by fluorescence microscopy.
Since there was an increase in cytoplasmic calcium con-
centration, we can therefore hypothesize that calcium
activated chloride channels (CaCC) could be involved.
Increased cytosolic calcium in host cells can be induced
by bacterial toxins [38]. We can therefore speculate that
S. aureus supernatant may be responsible for the time-
dependent increase in calcium concentration, followed
by the upregulation of CaCC and, as a consequence, an
activation of calcium-dependent chloride conductance.
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Page 12 of 15after incubation with S. aureus supernatant could be
associated with increasing mucin synthesis observed in
previous studies [39]. All these data suggest a general
mechanism by which epithelial glandular cells respond
to the presence of bacteria.
In a previous study [12], we have demonstrated that S.
aureus supernatant induced an upregulation of pro-
inflammatory molecules such as IL-8, IL-6 and TNFa at
mRNA and protein levels. We also reported that the
pre-incubation of airway cells with the combination of
Sal and FP had a beneficial effect in downregulating
inflammatory cytokines following S. aureus infection.
Pro-inflammatory mediator levels are markedly
increased in induced sputum of patients with COPD
[40]. The concentration of these mediators are further
increased during acute exacerbations [41] and a correla-
tion has been reported between pro-inflammatory med-
iator concentrations and the bacterial colony count in
sputum [42]. In our present study, we confirm that S.
aureus supernatant, even at low concentration, induces
am a r k e di n c r e a s ei nI L - 6 ,I L - 8a n dT N F a release by
airway glandular cells. Elevated TNFa levels are asso-
ciated with increased IL-8 levels, and TNFa is a major
inducer of IL-8 expression in lung epithelial cells [43].
In addition, TNFa which is increased by S. aureus
supernatant might also act on the regulation of CFTR
function. Indeed, it has been reported that this cytokine
was able to modulate ion secretion in different kind of
epithelia. Although it increases ion secretion in human
intestinal epithelium [44], TNFa attenuates b agonist-
evoked increase in chloride secretion across canine tra-
cheal epithelium [45]. Using epithelial cells expressing
wild-type CFTR or mutant CFTR lacking its PDZ-inter-
acting domain, Dudez et al [46] have demonstrated that
TNFa increased the amount of wild-type CFTR but not
mutant CFTR in detergent-resistant membrane micro-
domains in which CFTR interacts with TNFa receptor-1
signaling cascade to regulate cytokine expression.
Alteration of the formation of this complex may provide
an explanation to some dysfunction of epithelial cell
lacking a functional CFTR as observed in our study or
in CF. Some studies have shown that b2-AR agonists,
when given on their own, increased IL-8 release, but a
strong synergistic inhibitory interaction between b2-ago-
nists and steroids on IL-8 production has been
described [47]. Steroids increase b2-receptor synthesis
and b2-agonists prime glucocorticoid receptors for ster-
oid-dependent activation and enhance nuclear transloca-
tion [48]. Interestingly, post-treatment with the
combination of Sal/FP significantly reduced the IL-8 and
TNFa level compared with levels in S. aureus superna-
tant-treated cells.
Conclusion
The present data demonstrate that bacterial infection
may lead to severe disruption of ion transport across
the airway epithelium and to associated secretory gran-
ule dehydration, which may lead to defective mucocili-
ary clearance in the airways, as previously shown by
Puchelle et al who reported a relationship between the
degree of infection and the rheological and transport
properties of airway mucus in CF [8]. Together, our
data indicate that abnormal mucus and upregulation of
inflammatory cytokines associated with defective ion
transport could benefit from treatment with drugs that
could restore a normal function of secretory airway
cells.
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